Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03010137 · ClinicalTrials.gov registry record · NA
Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial
A NA study, sponsored by University of California, Davis.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03010137 is a NA study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 30 participants.
The verdict
NCT03010137, a NA study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Incisional negative pressure therapy (INPWT) has previously been shown in certain patient populations to decrease wound healing complications, decrease the rate of hematomas and seromas, as well as have better scar quality. We have found a group of patients, those who have panniculectomies in preparation for renal transplant, with significantly higher rates of wound healing complications. We believe the best way to demonstrate benefits of incisional negative pressure wound therapy will be in this group of patients known to have significantly higher rates of wound complications.
Interventions
- DEVICE Dermabond
- PROCEDURE Incisional Negative Pressure Wound Therapy
- PROCEDURE Standard Closure with Skin Glue
- DEVICE PICO (Smith&Nephew)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-12 |
| Est. Completion | 2019-03-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03010137
The ClinicalTrials.gov registry entry for NCT03010137 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Dermabond is the first listed.
NCT03010137 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03010137 about?
NCT03010137 is a clinical study titled "Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial". Incisional negative pressure therapy (INPWT) has previously been shown in certain patient populations to decrease wound healing complications, decrease the rate of hematomas and seromas, as well as have better scar quality. We have found a group of patients, those who have panniculectomies in prepar...
What is the current status of trial NCT03010137?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2015-12. Estimated completion is 2019-03-13.
What interventions are being tested in trial NCT03010137?
The interventions under investigation include: Dermabond (DEVICE), Incisional Negative Pressure Wound Therapy (PROCEDURE), Standard Closure with Skin Glue (PROCEDURE), PICO (Smith&Nephew) (DEVICE).
Who is sponsoring clinical trial NCT03010137?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.